AI's Role in Drug Discovery and Equity

SCSP’s Chair, Dr. Eric Schmidt discussed the convergence of artificial intelligence and biotechnology at last week’s AI+ Biotechnology Summit. The conversation delved into the rapid progress of AI, its potential impact on various industries, and the implications of underfunded science in the face of intense global competition.

Also check out last week’s episode with the Executive Director of the National Security Commission on Emerging Biotechnology, Caitlin Frazer, for a conversation on biotechnology’s national security impact. https://scsp222.substack.com/p/episode-74-caitlin-frazer-on-biotechnologys

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit scsp222.substack.com